Engineered platelets-based drug delivery platform for targeted thrombolysis

Thrombolytic agents have thus far yielded limited therapeutic benefits in the treatment of thrombotic disease due to their short half-life, low targeting ability, and association with serious adverse reactions, such as bleeding complications. Inspired by the natural roles of platelets during thrombu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Songli, Wang, Ruifeng, Meng, Nana, Lu, Linwei, Wang, Jun, Zhou, Jianfen, Lu, Jiasheng, Xu, Qianzhu, Xie, Cao, Zhan, Changyou, Li, Yao, Yu, Yang, Lu, Weiyue, Liu, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279721/
https://www.ncbi.nlm.nih.gov/pubmed/35847517
http://dx.doi.org/10.1016/j.apsb.2022.01.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279721/
https://www.ncbi.nlm.nih.gov/pubmed/35847517
http://dx.doi.org/10.1016/j.apsb.2022.01.004

Ejemplares similares